F10 and atrial fibrillation: C4. Antiplatelet agents in combination with vitamin K antagonist, direct thrombin inhibitor, or factor Xa inhibitors in patients with chronic atrial fibrillation, unless there is concurrent coronary artery stent(s) inserted or angiographically proven high-grade (>50%) coronary artery stenosis (no added benefit from antiplatelet agents)